Investors expect limited future growth, contributing to the ...

Investors expect limited future growth, contributing to the company's low P/S ratio. The underwhelming revenue outlook makes a strong share price rise unlikely.

FibroGen, Inc.'s (NASDAQ:FGEN) Price Is Right But Growth Is Lacking After Shares Rocket 95%

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

8198 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4331Followers

0Following

9509Visitors